Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
KYLYS logo — BIOMOLECULES NOW, FOR YOUR FUTURE

KYLYS

BIOMOLECULES NOW, FOR YOUR FUTURE

Founded 2017 Switzerland Plan-les-ouates, Switzerland 3 employees Debt Financing Total: $100.00K Biotechnology, Life Sciences +1

General Information

Company Name KYLYS
Founded Year 2017
Location Switzerland Plan-les-ouates, Switzerland +1
Employees 3
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Debt Financing
Social

Get notified when KYLYS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About KYLYS

KYLYS is a Life Science Spin-off from the University of Geneva, dedicated to advancing into clinical development. Their focus on science and biotechnology drives their ambition to pioneer a unique technology for highly effective and safe products utilizing the next generation of hyaluronic acid (HA). The company's offerings span across aesthetic and medical realms, under KYLYS Aesthetics and KYLYS respectively. KYLYS is positioned to disrupt the HA delivery landscape within various fields including aesthetic, rheumatology, reconstructive surgery, drug delivery system, and even veterinary applications. Founded in 2017 and headquartered in Switzerland, the latest injection of funds amounting to Fr.100.00K came in the form of Debt Financing from FONGIT on 16 May 2023. This recent investment signals confidence from a notable investor, accelerating KYLYS's trajectory towards groundbreaking advancements in biotechnology and the pharmaceutical industry.

Taxonomy: Life Science, Clinical Development, Hyaluronic Acid, Aesthetic Products, Medical Products, Rheumatology, Reconstructive Surgery, Drug Delivery, Veterinary Medicine, University Spin-off

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing •••••• 1
Investor
16 May 2023
Seed Round •••••• 1
Investor
01 Jan 2018

KYLYS Alternatives & Competitors

KYLYS vs
Omni Bioceuticals
Omni Bioceuticals United States

Make A Difference.

Seed
9 employees
Health Care, Medical Devices
KYLYS vs
Aesthetic Science Clinic
Aesthetic Science Clinic

Where beauty meets science, achieving optimal results through a comprehensive approach by skilled me...

Series A
17 employees
Health Care
KYLYS vs
Aesthetic Medical Supplies ApS
Aesthetic Medical Supplies ApS Denmark

We are a leading wholesaler selling products from the most popular brands in the aesthetic industry

3 employees

FAQ About KYLYS

BIOMOLECULES NOW, FOR YOUR FUTURE
KYLYS was founded in 2017.
KYLYS is headquartered in Plan-les-ouates, Switzerland.
KYLYS operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
KYLYS has approximately 3 employees.
KYLYS has completed 2 funding rounds, raising a total of $100.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to KYLYS include Omni Bioceuticals, Aesthetic Science Clinic, Aesthetic Medical Supplies ApS, Healthxchange, XTETIC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KYLYS and Omni Bioceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors KYLYS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy